Cristin-resultat-ID: 886773
Sist endret: 25. oktober 2016 14:33
NVI-rapporteringsår: 2012
Resultat
Vitenskapelig artikkel
2012

Effect of vaccines and antivirals during the major 2009 a(H1N1) pandemic wave in Norway – and the influence of vaccination timing

Bidragsytere:
  • Birgitte Freiesleben De Blasio
  • Bjørn Gunnar Iversen og
  • Gianpaolo Scalia Tomba

Tidsskrift

PLOS ONE
ISSN 1932-6203
e-ISSN 1932-6203
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2012
Volum: 7
Hefte: 1
Artikkelnummer: e30018
Open Access

Importkilder

Isi-ID: 000301353900034

Klassifisering

Vitenskapsdisipliner

Samfunnsmedisin, sosialmedisin

Emneord

Aldersgrupper • Norge • Vaksinasjon • Effekt

Beskrivelse Beskrivelse

Tittel

Effect of vaccines and antivirals during the major 2009 a(H1N1) pandemic wave in Norway – and the influence of vaccination timing

Sammendrag

To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI surveillance data from 5 October 2009 to 4 January 2010. We estimate a clinical attack rate of approximately 30% (28.7–29.8%), with highest disease rates among children 0–14 years (43–44%). Vaccination started in week 43 and came too late to have a strong influence on the pandemic in Norway. Our results indicate that the countermeasures prevented approximately 11–12% of potential cases relative to an unmitigated pandemic. Vaccination was found responsible for roughly 3 in 4 of the avoided infections. An estimated 50% reduction in the clinical attack rate would have resulted from vaccination alone, had the campaign started 6 weeks earlier. Had vaccination been prioritized for children first, the intervention should have commenced approximately 5 weeks earlier in order to achieve the same 50% reduction. In comparison, we estimate that a non-adjuvanted vaccination program should have started 8 weeks earlier to lower the clinical attack rate by 50%. In conclusion, vaccination timing was a critical factor in relation to the spread of the 2009 A(H1N1) influenza. Our results also corroborate the central role of children for the transmission of A(H1N1) pandemic influenza.

Bidragsytere

Birgitte Freiesleben de Blasio

Bidragsyterens navn vises på dette resultatet som Birgitte Freiesleben De Blasio
  • Tilknyttet:
    Forfatter
    ved Avdeling for metodeutvikling og analyse ved Folkehelseinstituttet
  • Tilknyttet:
    Forfatter
    ved Biostatistikk: Biostatistiske metoder og anvendelser ved Universitetet i Oslo

Bjørn Gunnar Iversen

  • Tilknyttet:
    Forfatter
    ved Avdeling for global helse ved Folkehelseinstituttet

Gianpaolo Scalia Tomba

  • Tilknyttet:
    Forfatter
    ved Università degli Studi di Roma Tor Vergata
  • Tilknyttet:
    Forfatter
    ved Statistisk analyse, maskinlæring og bildeanalyse SAMBA ved Norsk Regnesentral
1 - 3 av 3